Share-based Payment Arrangement, Expense of IMMUCELL CORP /DE/ from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IMMUCELL CORP /DE/ quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $73,161, a 5.7% decline year-over-year.
  • IMMUCELL CORP /DE/ Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $260,953, a 27% decline year-over-year.
  • IMMUCELL CORP /DE/ annual Share-based Payment Arrangement, Expense for 2024 was $325,551, a 12% decline from 2023.
  • IMMUCELL CORP /DE/ annual Share-based Payment Arrangement, Expense for 2023 was $368,866, a 39% increase from 2022.
  • IMMUCELL CORP /DE/ annual Share-based Payment Arrangement, Expense for 2022 was $266,244, a 84% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IMMUCELL CORP /DE/ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $260,953 $73,161 -$4,396 -5.7% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $265,349 $66,714 -$31,307 -32% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $296,656 $52,215 -$28,895 -36% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $325,551 $68,863 -$31,796 -32% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $357,347 $77,557 -$18,877 -20% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $376,224 $98,021 +$22,364 +30% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $353,860 $81,110 -$15,006 -16% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $368,866 $100,659 +$35,265 +54% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $333,601 $96,434 +$11,312 +13% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $322,289 $75,657 +$14,022 +23% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $308,267 $96,116 +$42,023 +78% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $266,244 $65,394 +$24,463 +60% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $241,781 $85,122 +$39,634 +87% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $202,147 $61,635 +$38,370 +165% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $163,777 $54,093 +$19,464 +56% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $144,313 $40,931 -$15,769 -28% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $160,082 $45,488 -$16,909 -27% 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 $176,991 $23,265 -$33,369 -59% 01 Apr 2021 30 Jun 2021 10-Q/A 21 Nov 2022 2022 Q2
Q1 2021 $210,360 $34,629 -$42,775 -55% 01 Jan 2021 31 Mar 2021 10-Q/A 21 Nov 2022 2022 Q1
Q4 2020 $253,135 $56,700 -$34,875 -38% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $288,010 $62,397 -$6,256 -9.1% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $294,266 $56,634 -$13,447 -19% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $307,713 $77,404 -$5,431 -6.6% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $313,144 $91,575 +$5,256 +6.1% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $307,888 $68,653 -$21,053 -23% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $328,941 $70,081 -$26,862 -28% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $355,803 $82,835 +$11,787 +17% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $344,016 $86,319 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $89,706 +$42,784 +91% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $96,943 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $71,048 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q3 2017 $46,922 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3

IMMUCELL CORP /DE/ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $325,551 -$43,315 -12% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $368,866 +$102,622 +39% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $266,244 +$121,931 +84% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $144,313 -$108,822 -43% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $253,135 -$60,009 -19% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $313,144 -$30,872 -9% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $344,016 +$144,233 +72% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $199,783 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.